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Abstract 
Purpose. 
To evaluate retinal structure and photoreceptor mosaic integrity 
in subjects with OPN1LW and OPN1MW mutations. 
Methods. 
Eleven subjects were recruited, eight of whom have been 
previously described. Cone and rod density was measured using 
images of the photoreceptor mosaic obtained from an adaptive optics 
scanning light ophthalmoscope (AOSLO). Total retinal thickness, inner 
retinal thickness, and outer nuclear layer plus Henle fiber layer 
(ONL+HFL) thickness were measured using cross-sectional spectral-
domain optical coherence tomography (SD-OCT) images. Molecular 
genetic analyses were performed to characterize the 
OPN1LW/OPN1MW gene array. 
Results. 
While disruptions in retinal lamination and cone mosaic 
structure were observed in all subjects, genotype-specific differences 
were also observed. For example, subjects with “L/M interchange” 
mutations resulting from intermixing of ancestral OPN1LW and 
OPN1MW genes had significant residual cone structure in the 
parafovea (∼25% of normal), despite widespread retinal disruption 
that included a large foveal lesion and thinning of the parafoveal inner 
retina. These subjects also reported a later-onset, progressive loss of 
visual function. In contrast, subjects with the C203R missense 
mutation presented with congenital blue cone monochromacy, with 
retinal lamination defects being restricted to the ONL+HFL and the 
degree of residual cone structure (8% of normal) being consistent with 
that expected for the S-cone submosaic. 
Conclusions. 
The photoreceptor phenotype associated with OPN1LW and 
OPN1MW mutations is highly variable. These findings have implications 
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for the potential restoration of visual function in subjects with opsin 
mutations. Our study highlights the importance of high-resolution 
phenotyping to characterize cellular structure in inherited retinal 
disease; such information will be critical for selecting patients most 
likely to respond to therapeutic intervention and for establishing a 
baseline for evaluating treatment efficacy. 
Introduction 
Mutations in the long-wavelength (L) and middle-wavelength 
(M) cone opsin genes (designated OPN1LW and OPN1MW, 
respectively) have been associated with a wide range of visual defects 
including red-green color vision deficiency, blue cone monochromacy 
(BCM), X-linked cone dystrophy, X-linked cone dysfunction, and high 
myopia with abnormal cone function.1–16 While characterization of 
visual function in these individuals is relatively straightforward, less is 
known about how the presence of OPN1LW and OPN1MW mutations 
affects retinal structure. Such information will be of paramount 
importance for advancing efforts to restore cone function in individuals 
with OPN1LW and OPN1MW mutations. 
Recent studies have shown that OPN1LW and OPN1MW 
mutations resulting in congenital red-green color vision defects are 
associated with a variable retinal phenotype, with some individuals 
showing disrupted cone structure and/or thinning of the outer nuclear 
layer (ONL).8,14,17,18 It is difficult to draw definite conclusions about the 
pathogenicity of a specific mutant from comparisons of these 
individuals, as there may be other factors influencing the retinal 
phenotype. For example, during development, there is competition 
between the first two genes in the X-chromosome opsin array in the 
nascent L/M cones that ends with only one of the two genes being 
expressed in each cell.19 It has been shown that the relative proportion 
of cones expressing each of the two genes in the L/M array varies 
widely (over 40-fold).20,21 Thus previously observed differences in 
retinal phenotype may be confounded by differences in the relative 
expression of the mutant opsin with respect to the normal opsin. As 
the degree of retained cone photoreceptor structure is related to the 
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therapeutic potential of a given retina,22 elucidation of genotype-
specific retinal phenotypes is essential. 
In one of the more serious vision disorders associated with 
OPN1LW and OPN1MW mutations, a single type of mutant opsin is 
expressed in all the cones that would have been L or M in a normal 
eye. In these subjects, rods and short-wavelength (S) cones are the 
only photoreceptors expressing normal photopigments. These 
individuals offer the opportunity to directly evaluate the effect of 
different OPN1LW and OPN1MW mutations. These mutations can be 
placed into one of three categories: (1) mutations that produced 
random nonhomologous missense substitutions at single amino acid 
positions1,3,12,16; (2) partial or complete deletion of an exon15,23; and 
(3) a recently identified category involving intermixing of ancestral 
OPN1LW and OPN1MW genes to produce “L/M interchange” mutations 
with deleterious combinations of nucleotides at normal polymorphic 
positions.7,8,10,13 While at least one L/M interchange mutation has been 
shown to directly cause cone malfunction (Greenwald SH, et al. IOVS 
2012;53:ARVO E-Abstract 4643), it was recently shown that in 
addition to any functional changes in the photopigment caused by the 
mutations, many of the L/M interchange mutations also interfere with 
recognition of exon 3 by the splicing mechanism.24 Some of the 
variants incompletely interfere with splicing, so full-length mRNA is 
produced as well as the inappropriately spliced transcript. Whether 
there are structural differences between the mutation categories, or 
for different mutations within a category, has been unknown. 
Here we used adaptive optics scanning laser ophthalmoscopy 
(AOSLO) and spectral-domain optical coherence tomography (SD-OCT) 
to examine 11 subjects for whom all cones except the S cones express 
one of six mutant opsins. There were differences in the anatomy and 
in the course and severity of vision loss across mutation categories. 
The subjects with L/M interchange mutations reported a later-onset 
progressive loss of visual function, while those with the C203R 
mutation showed a typical congenital BCM phenotype. We observed 
significant disruption of retinal lamination and of cone mosaic 
topography in all subjects, though the degree of disruption was 
generally greater for subjects with L/M interchange mutations than for 
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those with random mutations. These differences provide insight into 
the underlying mechanisms responsible for loss of structure and 
function in these subjects. Furthermore, while the cone loss observed 
may limit success of any efforts to restore L/M cone function using 
gene therapy in any of these subjects, it may be possible to develop 
strategies to slow or halt the degenerative changes in people harboring 
L/M interchange mutations. 
Methods 
Human Subjects 
Written informed consent was obtained after the nature and 
possible consequences of the study were explained. This study 
followed the tenets of the Declaration of Helsinki and was approved by 
all local ethics committees. We examined eight subjects for whom the 
clinical phenotype has been previously described and three new 
subjects (see Table and Supplementary Material, 
http://www.iovs.org/content/53/13/8006/suppl/DC1). Two male 
subjects (JC_0826, 22 years; JC_0847, 23 years) with normal color 
vision were included for comparison, and data from two previously 
published normative databases were used for comparison of the SD-
OCT studies. The data used for comparison against the horizontal line 
scans consisted of 93 subjects with an average age of 25.7 ± 8.2 
years,14 and the data used for comparison against the topographical 
thickness maps consisted of 60 subjects with an average age of 29 ± 
8.42 years.25 Axial length measurements were obtained on all subjects 
(Zeiss IOL Master; Carl Zeiss Meditec, Dublin, CA) in order to 
determine the scale (in microns per pixel) of each retinal image. Prior 
to all retinal imaging, each eye was dilated and cycloplegia was 
induced through topical application of a combination of phenylephrine 
hydrochloride (2.5%) and tropicamide (1%). 
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Subject 
 
Age, 
y 
 
Axial Length, 
mm (OD, OS) 
 
BCVA 
(OD, OS) 
 
L/M Array 
Structure 
 
L/M 
Mutation 
 
Source* 
 
JC_0183 16 25.65, 25.92 
20/80, 
20/80 
0L, 1M C203R† 
Fam. C, 
V:412 
JC_0184 13 24.85, 24.76 
20/120, 
20/120 
0L, 1M C203R† 
Fam. C, 
V:512 
JC_0440 18 25.49, 25.75 
20/80, 
20/80 
0L, 2M C203R† ‡ 
Fam. 1, 
2.115 
JC_0441 18 25.21, 25.12 
20/80, 
20/80 
0L, 2M C203R† ‡ 
Fam. 1, 
2.215 
JC_0355 31 24.54, 24.59 
20/80, 
20/125 
1L, 1M W177R§ ‡ IV:116 
JC_0356 30 25.90, 25.88 
20/125, 
20/125 
1L, 1M W177R§ ‡ IV:216 
JC_0347 32 24.77, 24.25 
20/125, 
20/125 
1L, 0M LVAVA|| This study 
JC_0564 45 27.08, 26.58 
20/100, 
20/100 
0L, 1M LVAVA|| This study 
JC_0118 32 25.83, 26.43 
20/40, 
20/40 
1L, 0M LIAVS|| 
MOL0250 
III:213 
KS_0577 38 23.71, 23.93 
20/70, 
20/100 
0L, 1M LVVVA|| This study 
JC_0430 26 25.40, 25.31 
20/120, 
20/120 
0L, 1M 
Exon 2 
deletion 
Fam. A, 
III:312 
 
Table.  Clinical and Genetic Summary 
Fam., Family. 
* Previous report of genotype and/or phenotype. 
† Substitution of cysteine (C) for arginine (R) at position 203. 
‡ Both genes in the array encode mutation. 
§ Substitution of tryptophan (W) for arginine at position 177. 
|| Sequence of polymorphic amino acids encoded by exon 3 of the L/M gene present in 
the subjects' L/M gene array (153, 171, 174, 178, 180). L, leucine; I, isoleucine; A, 
alanine; V, valine; S, serine. 
Molecular Genetics 
For the three newly recruited subjects, DNA was isolated from 
whole blood, and the opsin genes were amplified and sequenced using 
previously described methods.7 
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Spectral-Domain Optical Coherence Tomography 
Volumetric images of the macula were obtained using high-
definition OCT (Cirrus HD-OCT; Carl Zeiss Meditec). Volumes were 
nominally 6 mm × 6 mm and consisted of 128 B-scans (512 A-
scans/B-scan). Retinal thickness was calculated using the Macular 
Analysis software on the Cirrus (software version 5.0; Carl Zeiss 
Meditec), which is automatically determined via measurement of the 
difference between the inner limiting membrane (ILM) and retinal 
pigment epithelium (RPE) boundaries. High-resolution SD-OCT images 
of the macula were acquired (Bioptigen, Research Triangle Park, NC). 
High-density line scans (1000 A-scans/B-scan, 100 repeated B-scans) 
were acquired through the foveal center, then registered and averaged 
as previously described.26 No transformation (e.g., flattening), 
filtering, or other postprocessing was applied to these images. 
For retinal sublayer analysis, we manually segmented the ILM, 
the outer plexiform layer (OPL), the external limiting membrane 
(ELM), and the RPE on the high-resolution line scans as previously 
described using ImageJ (National Institute of Mental Health, Bethesda, 
MD).14 The ILM–RPE distance provides total retinal thickness, the ILM–
OPL distance provides the inner retinal thickness, and the OPL–ELM 
distance provides the ONL plus Henle fiber layer thickness (ONL+HFL). 
Adaptive Optics Retinal Imaging 
An adaptive optics scanning light ophthalmoscope (AOSLO) was 
used to obtain images of the photoreceptor mosaic at various retinal 
locations. JC_0183, JC_0184, JC_0440, JC_0441, JC_0355, JC_0356, 
JC_0118, and JC_0430 were imaged at the University of Rochester; 
details of this imaging system have been previously published.27 The 
remaining three subjects and the normal controls were imaged at the 
Medical College of Wisconsin, and details of this system have also been 
published.28 The systems derive from the basic design described by 
Gray et al.,29 with the afocal telescopes folded to varying degrees.27 
Both systems utilized a 97-channel deformable mirror (ALPAO, Biviers, 
France) as the wavefront corrector, with a Shack-Hartman wavefront 
sensor used to measure the wavefront. The imaging source was either 
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a 775 nm or a 796 nm super-luminescent diode (Inphenix Inc., 
Livermore, CA), and the light exposure was kept below the safe 
maximum permissible exposure set forth by ANSI.30,31 Images were 
processed to remove distortions induced by the sinusoidal motion of 
the resonant scanner by estimating the distortion from images of a 
calibrated Ronchi ruling and then resampling the images over a grid of 
equally spaced pixels. A separate calibration was done for each 
subject. Images were registered to improve signal-to-noise as 
previously described.32 
The registered images from each subject were combined into a 
single montage (Adobe Photoshop; Adobe Systems, Inc., San Jose, 
CA). This montage was scaled and aligned to the LSO image from the 
HD-OCT, in which a crosshair was placed at the center of the foveal 
pit. The scaling was based on theoretical magnification of each system 
and the alignment performed using blood vessel patterns. The 
locations to be analyzed were determined based on the distance from 
the center of the foveal pit, and the original image comprising that 
portion of the montage was set aside for subsequent density analyses. 
Cone density was measured at selected retinal locations (0.4, 0.8, 1.2, 
1.6, 2.0 mm) using manual identification of cone structures (80 μm × 
80 μm sampling window). For rod analysis, we utilized a smaller 
sampling window (55 μm × 55 μm) than we did for the cone density 
analysis, as the cones in these subjects were more sparse and 
irregularly spaced. Rod density was calculated at various locations 
between 0.5 and 3 mm using a previously described semiautomated 
algorithm in which the user could add/subtract missed or erroneous 
cell identifications.33 
Results 
Different Genotype Classes Associated with Distinct 
Clinical Phenotypes 
The Table provides a summary of subject demographics, with 
the clinical phenotype on 8 of the 11 having been reported previously. 
All four subjects with C203R mutations and the subject with the exon 2 
deletion presented a classical BCM phenotype, with vision based solely 
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on S cones and rods.12,15 The two brothers with W177R mutations 
(JC_0355 and JC_0356) had an onset in the first decade with no 
history of nystagmus; both showed subsequent deterioration of visual 
acuity and color vision, macular pigment epithelial disturbance, and 
severe generalized cone dysfunction on ERG.16 Both had good S-cone 
function with absent L/M cone function on psychophysical testing, 
though the data could not entirely exclude some residual L/M cone 
function in JC_0355.16 
The remaining four subjects (JC_0347, JC_0564, JC_0118, 
KS_0577) had OPN1LW and OPN1MW mutations that fell into the 
newly discovered category involving intermixing of ancestral genes to 
produce L/M interchange mutations with deleterious combinations of 
nucleotides at normal polymorphic positions in exon 3.7,8,10,13,19,24 All 
four of these subjects had a late-onset, progressive phenotype that 
was in stark contrast to that of the subjects with a C203R mutation or 
the exon 2 deletion (see Supplementary Material, 
http://www.iovs.org/content/53/13/8006/suppl/DC1). While the 
subjects with W177R mutations also had a progressive phenotype, it 
was earlier in onset than observed for the L/M interchange mutations 
and resulted in more complete loss of L/M cone function. 
Reduced Retinal Thickness in Subjects with OPN1LW 
and OPN1MW Mutations 
Topographical maps of retinal thickness show variable but 
significant macular thinning in individuals with all three classes of 
mutation (see Supplementary Material and Supplementary Fig. S1, 
http://www.iovs.org/content/53/13/8006/suppl/DC1). The average 
(±SD) central subfield (CSF) thickness (central 1 mm) for the 11 
subjects examined here was 194 ± 34 μm, compared to an average 
(±SD) value for 60 normal subjects from our lab of 266 ± 19 μm; P < 
0.0001, Mann-Whitney test.25 The subjects with random point 
mutations had more normal CSF thickness (216 ± 20 μm) than the 
individuals with L/M interchange mutations (174 ± 28 μm); P = 
0.0381, Mann-Whitney test. In addition, the retinal thinning in the 
subjects with L/M interchange mutations was more widespread (see 
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Supplementary Material and Supplementary Fig. S1, 
http://www.iovs.org/content/53/13/8006/suppl/DC1). 
To investigate the reduction in retinal thickness in more detail, 
we examined the thickness of the inner retina and the ONL+HFL from 
high-resolution horizontal cross sections (Fig. 1), and compared it to 
previously reported normative data.14 Consistent with the 
topographical thickness analysis, we observed that subjects with 
random point mutations had more normal total retinal thickness than 
subjects in the other two genetic categories (Fig. 2A). However, 
subjects with random point mutations had thinning restricted to the 
ONL+HFL, while subjects with L/M interchange mutations (LVAVA, 
LIAVS, and LVVVA) or the exon 2 deletion showed parafoveal thinning 
of the inner retina in addition to reduced ONL+HFL thickness (Figs. 2B, 
B,22C). 
 
Figure 1.   High-resolution SD-OCT images (horizontal line scans) through the 
fovea. Images are labeled with the subject ID and corresponding genotype. An image 
from a normal control (JC_0847) is shown for comparison (lower right). Four layers 
(labeled on the normal control scan) are associated with the hyperreflective 
photoreceptor complex, with layer 1 being attributed to the ELM and layer 2 to the 
ellipsoid portion of the inner segment (ISe). Layers 3 and 4 are thought to originate 
from different aspects of the RPE/photoreceptor interface and RPE, respectively.34 
Variable disruption of the ISe was observed across the 11 subjects. Scale bar is 200 
μm. 
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Figure 2.   Retinal thickness analysis along the horizontal meridian. (A) 
Total retinal thickness, (B) ONL+HFL thickness, (C) inner retinal thickness. 
Solid black line represents mean values for 93 normal controls, with shaded 
region representing ±2 SD from the mean. Filled circles represent averaged 
data for the C203R subjects (JC_0183, JC_0184, JC_0440, JC_0441); filled 
triangles represent averaged data for the W177R subjects (JC_0355, 
JC_0356); filled squares represent averaged data for the LVAVA subjects 
(JC_0347, JC_0564); open circles represent data for the LIAVS subject 
(JC_0118); open triangles represent data for the LVVVA subject (KS_0577); 
and open squares represent data for the subject with the exon 2 deletion 
(JC_0430). All subjects showed significant retinal thinning (total and 
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ONL+HFL), with only the C203R and W177R subjects having normal inner 
retinal thickness. 
Variable Appearance of Outer Photoreceptor Complex 
on SD-OCT in Subjects with OPN1LW and OPN1MW 
Mutations 
In the normal retina, at least four hyperreflective bands 
comprise the outer photoreceptor complex (see JC_0847 in Fig. 1). 
The innermost peak of the outer photoreceptor complex is attributed 
to the ELM, while the second layer is now thought to derive from the 
ellipsoid portion of the inner segment (ISe).34 The third layer is 
attributed to the RPE contact cylinder, and the fourth band is 
attributed to the RPE. As shown in Figure 1, we observed disruption of 
the ISe in all subjects; however, there were differences between the 
mutation classes that paralleled the differences in retinal thinning. Five 
of the six individuals with random point mutations (JC_0183, JC_0184, 
JC_0440, JC_0441, and JC_0355) had a focal disruption of the ISe 
near the foveal center. In contrast, subjects with L/M interchange 
mutations had generally greater disruption of the ISe: JC_0118 
(LIAVS) and KS_0577 (LVVVA) had a large area of ISe loss (as did the 
subject with the exon 2 deletion, JC_0430), and JC_0564 (LVAVA) 
showed diffuse mottling of the ISe. However, these differences did not 
segregate perfectly with genotype category, as JC_0347 (LVAVA) had 
a well-defined focal lesion and JC_0356 (W177R) had diffuse mottling 
of the ISe. 
In the six individuals with the focal ISe disruption, the 
boundaries of the disruption were marked using ImageJ35; the average 
(±SD) width was 99.2 ± 43.5 μm, consistent with previous estimates 
of the size of the S-cone free zone in humans.36–38 
Disrupted Foveal Cone Mosaic in Subjects with OPN1LW 
and OPN1MW Mutations 
Foveal montages created by stitching together multiple 
overlapping images are shown in Figure 3. Differences between the 
genotypic categories parallel those observed in the SD-OCT images. 
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We observed a hyporeflective area at or near the foveal center in the 
six aforementioned subjects with a focal ISe disruption on SD-OCT, 
consistent with this small area lacking healthy, waveguiding cones. A 
sparse population of hyperreflective cones, presumably S cones, 
surrounded this hyporeflective area. The three subjects with a larger 
area of ISe loss on SD-OCT had irregular areas of hyperreflectivity in 
the foveal montages with minimal cone structure present, consistent 
with disruption of L, M, and S foveal cones in their macula. The 
remaining two subjects had more diffuse photoreceptor mosaic 
disruption across the foveal montage with only sporadic 
hyperreflective cones, in keeping with the irregularly disrupted ISe. 
 
Figure 3.   Variable disruption of the central photoreceptor mosaic. AOSLO 
montages of the photoreceptor mosaic are shown, created by stitching together 
multiple overlapping images. The location of the foveal pit is marked with an asterisk, 
and the orientation of the montages is provided at the lower right (S, superior; I, 
inferior; N, nasal; T, temporal). The location and extent of disruption visualized in the 
AOSLO montages was consistent with that seen on the SD-OCT images. Scale bar is 
100 μm. 
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Shown in Figure 4 are plots of the putative S cones observed in 
the foveal montages for the six subjects with a discrete disruption of 
the ISe, compared to a plot of similar data from Curcio et al.38 While 
the analysis may not capture every S cone, it does provide a robust 
way to visualize the relative absence of reflective cones in a particular 
region. The size of the presumed S-cone free zone, determined by 
finding the largest circle that could be placed within the cone mosaic 
without encroaching on any cones, ranged from 50 to 120 μm, with an 
average of 72 μm for the six subjects. This is consistent with previous 
estimates of the size of the S-cone free zone,36–38 providing further 
support that the focal ISe represents complete loss of L/M cone 
structure in the foveola. Interestingly, the center of the presumed S-
cone free zone did not always align to the center of the foveal pit. 
 
Figure 4.   Visualizing the S-cone free zone. Shown are plots of putative S cones 
observed in the foveal montages for the six subjects with a discrete disruption of the 
ISe, compared to a plot of similar data from Curcio et al.38 Filled circles are manually 
identified cones near the foveal center, identified by their bright, Gaussian reflective 
profile. Open squares represent the center of the foveal pit, and it is worth noting that 
the center of the presumed S-cone free zone does not always align to the center of the 
foveal pit. The analysis may not capture every S cone, and thus may not provide 
accurate estimates of S-cone density; however, it does provide a robust way to map 
the relative absence of reflective cones in a particular region. The size of the presumed 
S-cone free zone, determined by finding the largest circle that could be placed within 
the cone mosaic without encroaching on any cones, ranged from 50 to 120 μm, with 
an average of 72 μm for the six subjects. Scale bar is 100 μm. 
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Residual Parafoveal L/M Cone Structure in Subjects 
with OPN1LW and OPN1MW Mutations 
The parafoveal cone mosaic in subjects with OPN1LW and 
OPN1MW mutations is severely disrupted compared to normal (Fig. 5). 
However, there are important differences between the genetic 
categories. Between L/M interchange mutations and those with C203R 
mutations and W177R mutations, the severity of the losses was 
reversed compared to that in the foveal region. While the macula was 
generally thinner and the foveal region more disrupted for the 
interchange mutations as a group, their parafoveal cone numbers were 
better preserved in the parafovea (Fig. 6). The difference was largest 
at 2 mm from the fovea, the most eccentric location measured. We 
were not able to resolve the rod mosaic in all subjects, but 
measurements made outside the central area of ISe disruption (visible 
on OCT) showed rod density consistent with that measured previously 
in normals with the same technique (Fig. 7).39 
 
Figure 5.   Disruption of the parafoveal photoreceptor mosaic. Eccentricity-
matched images from a normal (left) compared to those from four of the mutations 
studied here (middle and right) are shown. The eccentricity of each image is given as 
the distance from the foveal center. In the normal images, cones are the larger 
structures and rods the smaller ones. In the subjects with OPN1LW and OPN1MW 
mutations, there are fewer cones compared to normal and the rods appear larger, but 
they still comprise a contiguous mosaic. Scale bar is 50 μm. 
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Figure 6.   Genotype-dependent differences in retained cone structure. Solid 
gray bars represent the minimum and maximum S-cone density values reported in a 
previous histology study.38 Solid black bars represent averaged data for the C203R 
subjects (JC_0183, JC_0184, JC_0440, JC_0441), while the open bars represent 
averaged data for the W177R subjects (JC_0355, JC_0356). Filled squares represent 
averaged data for the LVAVA subjects (JC_0347, JC_0564); open circles represent 
data for the LIAVS subject (JC_0118); open triangles represent data for the LVVVA 
subject (KS_0577); and the open square represents data for the subject with the exon 
2 deletion (JC_0430). 
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Figure 7.   Parafoveal rod density in subjects with OPN1LW and OPN1MW 
mutations. It was not possible to visualize rods in all subjects or at systematic retinal 
locations, but in all areas assessed (eccentric to the central ISe disruption), we 
observed a contiguous rod mosaic of expected density. Subjects with C203R or W177R 
are plotted as open squares; subjects with L/M interchange mutations are plotted as 
filled circles; and the crosses represent normals measured using AOSLO from a 
previous study.39 The solid line is the average rod density from a previous histology 
report.40 
Assuming a starting cone density equal to that of an average 
normal,40 the residual density for the subjects with the random point 
mutations was 8.5% of normal (SD = 3.0%), consistent with what 
would be expected if they had only S cones remaining.37,38 In contrast, 
the subjects with L/M interchange mutations had residual densities 
that were on average 23% of normal (SD = 10.7%). Factoring in the 
expected population of S cones, we estimate that this corresponds to a 
loss of 86% of the L/M cones (SD = 9%). As normal cone density is 
highly variable, it is impossible to determine the exact degree of cone 
loss (or the degree of cone retention); however, it was clear that the 
retinas harboring C203R or W177R had very few, if any, residual L/M 
cones. Likewise, there was certainly residual L/M cone structure in 
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subjects with L/M interchange mutations, consistent with the residual 
L/M cone function measured with the ERG in KS_0577, JC_0347, and 
JC_0564 (Kuchenbecker J, et al. IOVS 2012; 53:ARVO E-Abstract 
6400). Structure/function agreement was also seen between the two 
subjects with the W77R mutation; JC_0355 had higher cone density 
and less retinal thinning than his brother (JC_0356), consistent with 
his slightly better vision in one eye and better L/M cone function on 
psychophysical testing.16 
Discussion 
Different Retinal Phenotypes in Subjects with OPN1LW 
and OPN1MW Mutations 
While all subjects had disrupted photoreceptor mosaics and 
reduced retinal thickness, there were significant differences between 
the mutation classes. The imaging results provide a number of insights 
into the basis for the observed phenotypic differences between the 
mutation categories. In general, the six subjects with random 
missense mutations (C203R and W177R) had the healthiest-appearing 
retinas on SD-OCT. The small disruption of the ISe that was present 
was shown to correspond to the S-cone free zone,36–38 with the focal 
loss of the ISe being the result of the absence of healthy L or M cones, 
S cones, or rods to provide structure at the foveal center. 
In contrast to the C203R and W177R mutations, the L/M 
interchange mutations (four subjects) and exon 2 deletion (one 
subject) appear to be more disruptive to the overall foveal 
architecture. Only one of five of these subjects (JC_0347, LVAVA) had 
a small focal disruption of the ISe; the others had diffuse mottling of 
the ISe or a much larger absence of the ISe (extending into the 
parafovea). Compared to the subjects with the random point 
mutations, these subjects had greater retinal thinning that involved 
the inner retina as well as the ONL. This suggests that these L/M 
interchange mutations cause, or are associated with, degenerative 
changes that result in damage to neighboring cells (S cones and rods) 
in addition to those expressing mutant L/M opsin. 
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The specificity of the photoreceptor damage to the macular 
region in the subjects with L/M interchange mutations is striking when 
images of the fovea are compared to more peripheral ones. Retinoid 
by-products of the visual cycle and all-trans-retinal (atRAL) are 
particularly toxic.41 It is possible that the cones expressing the L/M 
interchange mutants remain viable through young adulthood but are 
defective in their ability to participate normally in the visual cycle. This 
could lead to a buildup of atRAL or other toxic retinoids, affecting not 
only the cones expressing the mutant opsin, but also parafoveal S 
cones and rods. If these toxic by-products are concentrated in the 
fovea where the cone density is 20 times higher than in the peripheral 
retina,40 it could explain why the collateral damage is higher at the 
central retina compared to more eccentric locations (Fig. 1). 
Implications for Restoration of Visual Function in 
Subjects with OPN1LW and OPN1MW Mutations 
Advances in gene therapy have generated a great deal of 
excitement regarding the restoration of cone function in a variety of 
retinal diseases.42–48 While subjects with L/M interchange mutations 
had the greatest degree of residual parafoveal L/M cone structure, the 
presence of macular atrophy and inner retinal thinning in most of 
these subjects would limit the therapeutic opportunity in these 
individuals at later stages of the disease. However, strategies may be 
developed to slow the degenerative effects of these mutations. In 
contrast, the subjects with C203R or W177R mutations generally had 
more preserved retinal lamination, but adaptive optics imaging 
revealed no evidence for retained L/M cone structure. It is unclear 
whether any cone cell bodies remain, though given that rods appear to 
have expanded to fill in the space occupied by the cones, this would 
imply degeneration of at least the inner and outer segments. 
We did not examine subjects with deletions involving the locus 
control region (LCR), so it remains to be seen how complete absence 
of L/M opsin affects cone photoreceptor integrity compared to the 
expression of mutant opsin. Furthermore, we are unable to say if there 
are structural differences between individuals harboring different L/M 
interchange mutations. Previous evidence showed that an individual 
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with the LIAVA mutant expressed by one of the two genes in the L/M 
array had random, non-waveguiding cells throughout the cone mosaic, 
normal ISe integrity, normal inner retinal thickness, and no change in 
cone structure measured over a span of 8 years.8,18 This suggests that 
the LIAVA mutant may not result in the progressive loss of L/M cones 
(or does so on a much slower time scale), and it will be important to 
longitudinally assess the progressive nature of the various L/M 
interchange mutations to better determine the therapeutic potential in 
these individuals. 
In addition to using the imaging tools described here to 
prioritize potential subjects most suitable for intervention, by 
characterizing the degree of residual cone structure in subjects with 
OPN1LW and OPN1MW mutations, it will be valuable to employ the 
same techniques when evaluating the safety and efficacy of any future 
therapeutic intervention. Such an approach has already been 
demonstrated in patients with retinitis pigmentosa receiving ciliary 
neurotrophic factor,49 where preservation of cone structure was 
observed in the absence of a significant functional improvement in 
vision. It is entirely plausible that structural recovery or preservation 
precedes functional changes; however, this will remain unclear until 
high-resolution imaging metrics become a routine part of the outcome 
measures used in clinical trials. 
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